Ceva price target raised to $41 from $35 at Barclays

Barclays analyst Tavy Rosner raised the firm’s price target on Ceva to $41 from $35 and keeps an Overweight rating on the shares post the Q4 results. The analyst says strength in license revenues was offset by a decline in royalties. The firm believes management’s focus on cost control and growth drivers combined with Ceva’s solid cash position will allow the company to manage the short-term weakness.